Neuro-inflammatory risk factors for treatment failure in "early second stage" sleeping sickness patients treated with pentamidine.
about
Chemotherapy for second-stage Human African trypanosomiasisOptions for field diagnosis of human african trypanosomiasisIn vivo imaging of trypanosome-brain interactions and development of a rapid screening test for drugs against CNS stage trypanosomiasisDiagnostic accuracy of PCR in gambiense sleeping sickness diagnosis, staging and post-treatment follow-up: a 2-year longitudinal study.Cerebrospinal fluid neopterin as marker of the meningo-encephalitic stage of Trypanosoma brucei gambiense sleeping sickness.Treatment failure related to intrathecal immunoglobulin M (IgM) synthesis, cerebrospinal fluid IgM, and interleukin-10 in patients with hemolymphatic-stage sleeping sicknessTrypanosomiasis and the brain.Chemotherapy against human African trypanosomiasis: is there a road to success?Therapy of vector-borne protozoan infections in nonendemic settings.Drug resistance in human African trypanosomiasis.Pentamidine movement across the murine blood-brain and blood-cerebrospinal fluid barriers: effect of trypanosome infection, combination therapy, P-glycoprotein, and multidrug resistance-associated protein.
P2860
Q24201785-096B7C9A-B0CE-46FD-B93B-724F42249DABQ24557540-C3F5FFA1-7584-4251-91F8-4B993E6ECF8EQ27305075-732F64AB-02CB-4A11-9785-C3E3F5E1B1D0Q33834052-5F3DDEBE-5A03-4864-AE3B-BAF1EC860340Q34345396-3380C863-7158-4882-8EEE-1D2FE17313D8Q35946968-172C165B-5DDC-4707-A0DC-B39D682AD6DCQ37661154-DFED5309-518E-43D0-9274-B782587D8421Q37801690-6771DCF3-E9A8-4056-8736-72D0F39CFCE3Q37879203-840D732D-C2EB-4754-9D02-2E75C23ED82EQ37940573-F274F010-6991-499A-99BC-E355E4806099Q43125242-219B59B6-D8CE-4CF0-AF97-3CFE211891DD
P2860
Neuro-inflammatory risk factors for treatment failure in "early second stage" sleeping sickness patients treated with pentamidine.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
2003年论文
@zh
2003年论文
@zh-cn
name
Neuro-inflammatory risk factor ...... ents treated with pentamidine.
@en
Neuro-inflammatory risk factor ...... ents treated with pentamidine.
@nl
type
label
Neuro-inflammatory risk factor ...... ents treated with pentamidine.
@en
Neuro-inflammatory risk factor ...... ents treated with pentamidine.
@nl
prefLabel
Neuro-inflammatory risk factor ...... ents treated with pentamidine.
@en
Neuro-inflammatory risk factor ...... ents treated with pentamidine.
@nl
P2093
P1476
Neuro-inflammatory risk factor ...... ents treated with pentamidine.
@en
P2093
Alexia Savignoni
Dawson Mbulamberi
Dominique Legros
Marc Gastellu Etchegorry
P304
P356
10.1016/J.JNEUROIM.2003.08.033
P577
2003-11-01T00:00:00Z